These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 5596210)

  • 1. Susceptibility of gram-negative pathogens to the combination of dicloxacillin and hetacillin.
    McKee WM; Turck M
    Antimicrob Agents Chemother (Bethesda); 1967; 7():705-10. PubMed ID: 5596210
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro evaluation of the hetacillin/dicloxacillin antibiotic combination.
    Bulger RJ; Nielson K
    Am J Med Sci; 1968 Sep; 256(3):155-65. PubMed ID: 5303030
    [No Abstract]   [Full Text] [Related]  

  • 3. Penicillin combinations against multi-resistant urinary pathogens as an alternative to gentamycin treatment.
    Gnarpe H; Alfredsson H; Börstad B
    Microbios; 1976; 16(65-66):201-6. PubMed ID: 18651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies of BL-P1462, a new semisynthetic penicillin with anti-pseudomonas activity.
    Barza M; Berman H; Michaeli D; Molavi A; Weinstein L
    Antimicrob Agents Chemother (Bethesda); 1970; 10():341-5. PubMed ID: 5521354
    [No Abstract]   [Full Text] [Related]  

  • 5. Laboratory and clinical studies of carbenicillin against gram-negative bacilli.
    Standiford HC; Kind AC; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1968; 8():286-91. PubMed ID: 5735373
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience on the effectiveness of carbenicillin against gram negative bacilli and gram positive cocci in the agar diffusion test].
    Müller J
    Med Welt; 1970 Jan; 4():147-8. PubMed ID: 4986305
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug resistance mechanism of gram negative bacilli].
    Yokota T
    Nihon Rinsho; 1977; 35(3):1402-8. PubMed ID: 585743
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sensitivity to mezlocillin Gram-negative aerobic bacilli according to their pattern of resistance to the usual beta-lactam antibiotics (author's transl)].
    Witchitz JL; Faurisson F; Christol D
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):314-7. PubMed ID: 6460966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transferable resistance to azlocillin (Securopen)].
    Antal M; Krcméry V; Zikmundová V; Menkyna R; Sirági P; Výmola F
    Cesk Epidemiol Mikrobiol Imunol; 1983 Jul; 32(4):204-10. PubMed ID: 6225535
    [No Abstract]   [Full Text] [Related]  

  • 10. The action of some beta-lactam antibiotics on the penicillin-binding proteins of Gram-negative bacteria.
    Curtis NA; Orr DC; Boulton MG
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):368-70. PubMed ID: 6109334
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
    Dzierzanowska D; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):346-55. PubMed ID: 6417945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sensitivity of bacteria isolated from non-parenteral drugs to antibiotics. III. Evaluation of sensitivity of gram-negative strains].
    Zembrzuska E
    Acta Pol Pharm; 1981; 38(2):249-53. PubMed ID: 7032218
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains].
    Mascellino MT; Prignano G; Lorenzi A; Iegri F; Martorano E; Catania S; Ginanni Corradini S
    Boll Ist Sieroter Milan; 1984; 63(5):447-52. PubMed ID: 6335660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative in vitro activity of 5 semi-synthetic penicillins against aerobic Gram-negative bacilli and enterococci (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):318-23. PubMed ID: 6460967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heavy metal and disinfectant resistance in clinical isolates of gram-negative rods.
    Khor SY; Jegathesan M
    Southeast Asian J Trop Med Public Health; 1983 Jun; 14(2):199-203. PubMed ID: 6635758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory concentrations of cefoperazone, cefazolin, cefamandole, cephaloridine, and cefoxitin for 300 gram-negative clinical isolates.
    Trabulsi LR; Pereira da Silva Almada N; Marques LR
    Clin Ther; 1980; 3(Spec Issue):145-8. PubMed ID: 6446390
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial activity of beta-lactams against multiresistant micro-organisms from the family Enterobacteriaceae, and genus Pseudomonas.
    Niebla A; González I; Vallín C
    Microbios; 1994; 80(325):245-50. PubMed ID: 7700163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro activity of fosfomycin].
    Ceruti T; Biazzi E; D'Avossa I; Pennacchio A; Santini F
    Arch Sci Med (Torino); 1980; 137(2):221-4. PubMed ID: 7224844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.